Clinical implementation of pharmacogenomics: ov... [Lancet Oncol. 2010] - PubMed

loading

The ethics of CYP2D6 testing for patients considering tamoxifen. [Breast Cancer Res. 2007]
The ethics of CYP2D6 testing for patients considering tamoxifen.
Hartman AR, Helft P. Breast Cancer Res. 2007; 9(2):103.
Practical considerations for pharmacogenetic testing. [MLO Med Lab Obs. 2001]
Practical considerations for pharmacogenetic testing.
Wedlund PJ. MLO Med Lab Obs. 2001 Sep; 33(9):16-21, 23; quiz 24-5.
[Pharmacogenetics in pediatrics]. [Arch Pediatr. 2001]
[Pharmacogenetics in pediatrics].
Jacqz-Aigrain E. Arch Pediatr. 2001 May; 8 Suppl 2:342s-344s.
Review Pharmacogenetic screening and therapeutic drugs. [Clin Chim Acta. 2002]
Review Pharmacogenetic screening and therapeutic drugs.
Steimer W, Potter JM. Clin Chim Acta. 2002 Jan; 315(1-2):137-55.
Review [Thiopurine methyltransferase (TPMP) polymorphism: a model of clinical application for pharmacogenetics]. [Pol Arch Med Wewn. 2003]
Review [Thiopurine methyltransferase (TPMP) polymorphism: a model of clinical application for pharmacogenetics].
Kurzawski M, Droździk M. Pol Arch Med Wewn. 2003 May; 109(5):535-40.

Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. [Front Genet. 2012]
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.
Stocco G, Franca R, Verzegnassi F, Londero M, Rabusin M, Decorti G. Front Genet. 2012; 3:309. Epub 2013 Jan 7.
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. [Front Genet. 2012]
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.
Agúndez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borrás E, Carballo M, Carvajal A, García-Muñiz JD, et al. Front Genet. 2012; 3:273. Epub 2012 Nov 26.
Role of cytochrome P450 genotype in the steps toward personalized drug therapy. [Pharmgenomics Pers Med. 2011]
Role of cytochrome P450 genotype in the steps toward personalized drug therapy.
Cavallari LH, Jeong H, Bress A. Pharmgenomics Pers Med. 2011; 4:123-36. Epub 2011 Nov 7.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.
Lancet Oncol. 2010 Jun ;11(6):507-9. doi: 10.1016/S1470-2045(10)70097-8. Epub 2010 Apr 21 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed